Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mgA Randomized, Open-Label, Crossover, Single-Centre Study

被引：0

作者：

Mona Darwish

Fang Xie

机构：

[1] Cephalon,Department of Clinical Pharmacology

[2] Inc.,Biometrics Department

[3] Cephalon,undefined

[4] Inc.,undefined

来源：

Clinical Drug Investigation | 2009年 / 29卷

关键词：

Oxybutynin; Food Effect; Tizanidine; Study Drug Administration; Aphthous Stomatitis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background and objective: Food can alter the bioavailability of the controlled-release formulations of many different drugs. This study assessed the effect of food on the pharmacokinetics of once-daily cyclobenzaprine extended-release (CER) in healthy adult subjects.

引用

页码：145 / 152

页数：7

共 50 条

[21] Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies
Preskorn, Sheldon
Ereshefsky, Larry
Chiu, Yu-Yuan
Poola, Nagaraju
Loebel, Antony
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (05) : 495 - 505
[22] Long-term safety and effectiveness of once-daily, single-entity, extended-release hydrocodone over 76 weeks of an open-label study in patients with chronic noncancer and nonneuropathic pain
Taber, Louise
Lynch, Shau Yu
He, Ellie
Ripa, Steven R.
POSTGRADUATE MEDICINE, 2016, 128 (01) : 23 - 33
[23] Pharmacokinetics for Once-Daily Versus Twice-Daily Tacrolimus Formulations in De Novo Liver Transplantation: A Randomized, Open-Label Trial
Fischer, Lutz
Trunecka, Pavel
Gridelli, Bruno
Roy, Andre
Vitale, Alessandro
Valdivieso, Andres
Varo, Evaristo
Seehofer, Daniel
Lynch, Stephen
Samuel, Didier
Ericzon, Bo-Goran
Boudjema, Karim
Karpf, Carmen
Undre, Nasrullah
LIVER TRANSPLANTATION, 2011, 17 (02) : 167 - 177
[24] Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study
Simon, JA
Lewiecki, EM
Smith, ME
Petruschke, RA
Wang, LX
Palmisano, JJ
CLINICAL THERAPEUTICS, 2002, 24 (11) : 1871 - 1886
[25] Conversion of once-daily extended-release tacrolimus is safe in stable liver transplant recipients: A randomized prospective study
Kim, Jong Man
Kwon, Choon Hyuck David
Joh, Jae-Won
Sinn, Dong Hyun
Lee, Sanghoon
Choi, Gyu-Seong
Lee, Suk-Koo
LIVER TRANSPLANTATION, 2016, 22 (02) : 209 - 216
[26] The Conversion of Once-Daily Extended-Release Tacrolimus Is Safe in Stable Liver Transplant Recipients: A Randomized Prospective Study
Kim, Jong Man
Sinn, Dong Hyun
Lee, Sanghoon
Choi, Gyu-Seong
Kwon, Choon Hyuck D.
Joh, Jae-Won
Lee, Suk-Koo
TRANSPLANTATION, 2016, 100 : S89 - S89
[27] Safety and Tolerability of Once-Daily, Extended-Release Memantine in Patients with Moderate to Severe Alzheimer's Disease: Results of a 52-Week Open-Label Trial
Meyers, Barnett S.
Lin, Min
Graham, Stephen M.
ANNALS OF NEUROLOGY, 2010, 68 (04) : S49 - S50
[28] Long-Term, Open-Label Safety and Tolerability Study of Once-Daily Extended-Release Oxcarbazepine (SPN-804) as Adjunctive Therapy in Patients with Refractory Partial Seizures
Johnson, Janet
Brittain, Scott
Louro, Dawn
NEUROLOGY, 2013, 80
[29] Dosage Form Proportionality and Food Effect of the Final Tablet Formulation of Eslicarbazepine AcetateRandomized, Open-Label, Crossover, Single-Centre Study in Healthy Volunteers
Carlos Fontes-Ribeiro
Tice Macedo
Teresa Nunes
Carla Neta
Teófilo Vasconcelos
Rui Cerdeira
Ricardo Lima
José-Francisco Rocha
Amílcar Falcão
Luís Almeida
Patrício Soares-da-Silva
Drugs in R & D, 2008, 9 : 447 - 454
[30] Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
Nassim Kamar
Elisabeth Cassuto
Giovanni Piotti
Mirco Govoni
Giorgia Ciurlia
Silvia Geraci
Gianluigi Poli
Gabriele Nicolini
Christophe Mariat
Marie Essig
Paolo Malvezzi
Yannick Le Meur
Valerie Garrigue
Arnaud Del Bello
Lionel Rostaing
Advances in Therapy, 2019, 36 : 462 - 477

← 1 2 3 4 5 →